Techniques & Technology

Options for Non-Venous Wounds: Diabetic Foot Ulcers

As wound care providers, we hold people’s lives in our hands. The five-year mortality rate of a person with a neuropathic foot ulcer is 45%, compared to 11% for a patient with breast cancer and 35% for a patient wit...Continue Reading


Effective Vascular Interventions: Are We Comparing Apples to Cows?

How do your patients define success? Do they use the same definition that you do? Most vein specialists would describe a successful outcome as occlusion of the affected vein, elimination of reflux, improved disease severi...Continue Reading


Sclerotherapy for Telangiectasia and Reticular Veins

It has been estimated that between 10% and 20% of the adult U.S. and Western European populations have varicose veins and up to 50% of women by age 50 will have telangiectatic leg veins. The difference between varicose, r...Continue Reading


Venous Duplex – 2 Sides of the Coin

I am often asked a myriad of questions relating to the duplex examination for chronic venous insufficiency (CVI) or venous reflux. More and more physicians and technologists are entering the field of phlebology, from back...Continue Reading


Better Visualization: A Closer look at Syris Scientific’s v900L

Hands-free polarized headset lights for enhanced visualization to medical professionals performing vascular procedures, as well as other treatments that benefit from seeing below the surface of the skin, have been an asse...Continue Reading


Runnin' Down a Dream: A Round Table Discussion on Artificial Vein Valves

Steve Elias: Welcome, everybody. We are going to be speaking about the Holy Grail of venous disease that is somehow gaining a functioning valve in the deep venous system. All of you have been intimately involved with veno...Continue Reading


IVC Filters and the Recent Trials

Common indications for IVC filter insertion include patients who have documented VTE and have failed anticoagulation, or those who have contraindications to anticoagulation, such as active bleeding, recent intracranial he...Continue Reading


The Next Essential: A New Core Lab Comes of Age

What are the attributes of a core lab? The concept of core lab utilization has become an integral part of clinical trial design and management during the past couple of decades. A core lab’s primary purpose is to e...Continue Reading


The ASVAL Story

by Paul Pittaluga, MD & Sylvain Chastanet, MD We published some years ago a new approach for the treatment of varicose veins (VVs) called ASVAL (Ambulatory Selective Varices Ablation under Local anesthesia), which...Continue Reading


The ATTRACT Trial

Acute DVT, PTS and Streptokinase It is well established that patients who present with acute deep vein thrombosis (DVT) of the lower extremity have a high prevalence of developing post thrombotic syndrome (PTS) if trea...Continue Reading